SPOTLIGHT -
From Extraneal to Onconase
Treatment For Rare Immunodeficiency Disease Gets FDA Approval
The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.
Mental Health and CBD: What's the Latest Info
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All
Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.
What CBD Brings to the Table for Dermatologic Concerns
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for in dermatology.
Vaccines, Variants, and More: COVID-19 Year in Review
From variants to vaccines, much has changed in the COVID-19 landscape.
Pharmacogenetic Testing, Therapeutic Drug Monitoring Feasible to Monitor Sertraline Concentrations in Residential Treatment Setting
Pharmacogenetic testing and therapeutic drug monitoring are feasible in the inpatient psychiatric treatment setting.
